CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Validation of acute myocardial infarction in the Food and Drug Administration\u27s Mini-Sentinel program
Authors
Denise M. Boudreau
Melissa G. Butler
+13 more
Sarah L. Cutrona
Gregory W. Daniel
Susan Forrow
Sarah Foy
Robert J. Goldberg
Joel M. Gore
Jerry H. Gurwitz
Aarthi Iyer
David D. McManus
Vinit P. Nair
Daniel Ng
Judith A. Racoosin
Sengwee Toh
Publication date
1 January 2013
Publisher
eScholarship@UMassChan
Abstract
PURPOSE: To validate an algorithm based upon International Classification of Diseases, 9(th) revision, Clinical Modification (ICD-9-CM) codes for acute myocardial infarction (AMI) documented within the Mini-Sentinel Distributed Database (MSDD). METHODS: Using an ICD-9-CM-based algorithm (hospitalized patients with 410.x0 or 410.x1 in primary position), we identified a random sample of potential cases of AMI in 2009 from four Data Partners participating in the Mini-Sentinel Program. Cardiologist reviewers used information abstracted from hospital records to assess the likelihood of an AMI diagnosis based on criteria from the Joint European Society of Cardiology and American College of Cardiology Global Task Force. Positive predictive values (PPVs) of the ICD-9-based algorithm were calculated. RESULTS: Of the 153 potential cases of AMI identified, hospital records for 143 (93%) were retrieved and abstracted. Overall, the PPV was 86.0% (95% confidence interval; 79.2%, 91.2%). PPVs ranged from 76.3% to 94.3% across the four Data Partners. CONCLUSIONS: The overall PPV of potential AMI cases, as identified using an ICD-9-CM-based algorithm, may be acceptable for safety surveillance; however, PPVs do vary across Data Partners. This validation effort provides a contemporary estimate of the reliability of this algorithm for use in future surveillance efforts conducted using the Food and Drug Administration\u27s MSDD. Copyright © 2012 John Wiley & Sons, Ltd
Similar works
Full text
Available Versions
eScholarship@UMMS
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:escholarship.umassmed.edu:...
Last time updated on 12/11/2016